News
Harvard Quietly Resolves Anti-Palestinian Discrimination Complaint With Ed. Department
News
Following Dining Hall Crowds, Harvard College Won’t Say Whether It Tracked Wintersession Move-Ins
News
Harvard Outsources Program to Identify Descendants of Those Enslaved by University Affiliates, Lays Off Internal Staff
News
Harvard Medical School Cancels Class Session With Gazan Patients, Calling It One-Sided
News
Garber Privately Tells Faculty That Harvard Must Rethink Messaging After GOP Victory
Some personal characteristics of Dr. Henry A. Murray '15, University psychologist, were attacked by Assistant United States Attorney Thomas E. Murphy, prosecutor in the Alger Biss LL.B. '29 trial, last Friday.
Earlier in the week Dr. Murray said that Whittaker Chambers, the chief witness for the prosecution had a "psychopathic personality" and was an accuser who tried to "smear, degrade, and destroy a valued person."
Murphy, cross-examining the psychologist, asked: "Doctor, would you describe your personality as normal?"
"Relatively," Dr. Murray replied.
Mouth Twitches
Murphy replied that "there is no such thing as normal." The prosecution continued: "Would it be of any significance to you if you noticed that a subject's mouth twitched, that his eyes opened and closed, that he had excessive hand gestures, that he played with his watch chain and his glasses and his nose, that he turned his head constantly and breathed heavily through his nose?"
"No sir," replied Dr. Murray.
Dr. Murray had displayed some of the characteristics mentioned while under direct examination Thursday.
Disorder Incurable
The Harvard psychologist charged in his earlier testimony that Hiss' accuser had an incurable mental disorder. He said there was a saying "that once a psychopath, always a psychopath." His diagnosis was in agreement with that of Dr. Carl O. Binger '10, New York psychiatrist.
Dr. Murray made an analysis of Adolph Hitler for the government during the war and predicted the German dictator's suicide.
Want to keep up with breaking news? Subscribe to our email newsletter.